Detoxification and DNA repair genes polymorphisms and susceptibility of primary myelodysplastic syndromes in Chinese population

Leukemia Research

Volumn 35, Issue 6, 2011, Pages 762-765

  Li, Lin ^a   Yang, Lin ^a   Zhang, Yue ^a   Xu, Zefeng ^a   Qin, Tiejun ^a   Hao, Yushu ^a   Xiao Zhijian, Z ^a  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

Author keywords

Detoxification; DNA repair; Karyotype; Myelodysplastic syndromes; Polymorphisms; Susceptibility

Indexed keywords

DNA; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; RAD51 PROTEIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); XRCC3 PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHINESE; CHROMOSOME ANALYSIS; CONTROLLED STUDY; DETOXIFICATION; DNA POLYMORPHISM; DNA REPAIR; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; RISK FACTOR; SEX CHROMOSOME ABERRATION; STRUCTURAL CHROMOSOME ABERRATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; KARYOTYPING; LOGISTIC MODELS; MALE; METABOLIC DETOXICATION, DRUG; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RAD51 RECOMBINASE; YOUNG ADULT;

EID: 79955653405     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.12.001     Document Type: Article

References (26)

1. Willman C.L. Molecular genetic features of myelodysplastic syndromes (MDS). Leukemia 1998, 12(1):S2-S6.
2. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature 2001, 411:366-374.
3. Fabiani E., D'Alo F., Scardocci A., Greco M., Di Ruscio A., Criscuolo M., et al. And others polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes. Leuk Res 2009, 33:1068-1071.
4. Chen H., Sandler D.P., Taylor J.A., Shore D.L., Liu E., Bloomfield C.D., et al. Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet 1996, 347:295-297.
5. Sasai Y., Horiike S., Misawa S., Kaneko H., Kobayashi M., Fujii H., et al. Genotype of glutathione S-transferase and other genetic configurations in myelodysplasia. Leuk Res 1999, 23:975-981.
6. Tsabouri S.E., Georgiou I., Alamanos I., Bourantas K.L. Increased prevalence of GSTM(1) null genotype in patients with myelodysplastic syndrome: a case-control study. Acta Haematol 2000, 104:169-173.
7. Naoe T., Takeyama K., Yokozawa T., Kiyoi H., Seto M., Uike N., et al. Others analysis of genetic polymorphism in NQO1, GST-M1 GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res 2000, 6:4091-4095.
8. Dahabreh I.J., Giannouli S., Gota V., Voulgarelis M. GSTT1, and GSTM1 polymorphisms and myelodysplastic syndrome risk: a systematic review and meta-analysis. Int J Cancer 2010, 126:1716-1723.
9. Yang L., Zou X., Zhang M.R., Zhang Y., Hao Y.S., Xiao Z.J. Investigation of GSTT1, GSTM1 and NQO1 genes polymorphisms in myelodysplastic syndromes. Zhonghua Xue Ye Xue Za Zhi 2005, 26:674-677.
10. Baumann Kreuziger L.M., Steensma D.P. RAD51 and XRCC3 polymorphism frequency and risk of myelodysplastic syndromes. Am J Hematol 2008, 83:822-823.
11. Vardiman J.W., Harris N.L., Brunning R.D. The World Health Organization (WHO) classification of the myeloid neoplasms. Blood 2002, 100:2292-2302.
12. Seedhouse C., Faulkner R., Ashraf N., Das-Gupta E., Russell N. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia. Clin Cancer Res 2004, 10:2675-2680.
13. Valent P., Horny H.P., Bennett J.M., Fonatsch C., Germing U., Greenberg P., et al. Others definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference. Leuk Res 2007, 31:727-736.
14. Vijayakrishnan J., Houlston R.S. Candidate gene association studies and risk of childhood acute lymphoblastic leukemia: a systematic review and meta-analysis. Haematologica 2010, 95:1405-1414.
15. Baumann P., Benson F.E., West S.C. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro. Cell 1996, 87:757-766.
16. Bolufer P., Barragan E., Collado M., Cervera J., Lopez J.A., Sanz M.A. Influence of genetic polymorphisms on the risk of developing leukemia and on disease progression. Leuk Res 2006, 30:1471-1491.
17. Preudhomme C., Nisse C., Hebbar M., Vanrumbeke M., Brizard A., Lai J.L., et al. S transferase theta 1 gene defects in myelodysplastic syndromes and their correlation with karyotype and exposure to potential carcinogens. Leukemia 1997, 11:1580-1582.
18. Varkonyi J., Szakaly D., Janoskuti L., Hosszufalusi N., Panczel P., Karadi I., et al. Glutathione S-transferase enzyme polymorphisms in a Hungarian myelodysplasia study population. Pathol Oncol Res 2008, 14:429-433.
19. Basu T., Gale R.E., Langabeer S., Linch D.C. Glutathione S-transferase theta 1 (GSTT1) gene defect in myelodysplasia and acute myeloid leukaemia. Lancet 1997, 349:1450.
20. Atoyebi W., Kusec R., Fidler C., Peto T.E., Boultwood J., Wainscoat J.S. Glutathione S-transferase gene deletions in myelodysplasia. Lancet 1997, 349:1450-1451.
21. Okada M., Okamoto T., Wada H., Takemoto Y., Kakishita E. Glutathione S-transferase theta 1 gene (GSTT1) defect in Japanese patients with myelodysplastic syndromes. Int J Hematol 1997, 66:393-394.
22. Xiao Z., Yang L., Xu Z., Zhang Y., Liu L., Nie L., et al. Glutathione S-transferases (GSTT1 and GSTM1) genes polymorphisms and the treatment response and prognosis in Chinese patients with de novo acute myeloid leukemia. Leuk Res 2008, 32:1288-1291.
23. Larson R.A., Wang Y., Banerjee M., Wiemels J., Hartford C., Le Beau M.M., et al. Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood 1999, 94:803-807.
24. Kiuru A., Lindholm C., Heilimo I., Ceppi M., Koivistoinen A., Ilus T., et al. Influence of DNA repair gene polymorphisms on the yield of chromosomal aberrations. Environ Mol Mutagen 2005, 46:198-205.
25. Zintzaras E., Kitsios G.D. Synopsis and synthesis of candidate-gene association studies in chronic lymphocytic leukemia: the CUMAGAS-CLL information system. Am J Epidemiol 2009, 170:671-678.
26. Weiss J.R., Baer M.R., Ambrosone C.B., Blanco J.G., Hutson A., Ford L.A., et al. Concordance of pharmacogenetic polymorphisms in tumor and germ line DNA in adult patients with acute myeloid leukemia. Cancer Epidemiol Biomarkers Prev 2007, 16:1038-1041.